Literature DB >> 1664488

IgG subclass-specific antibodies to human cytomegalovirus (HCMV)-induced early antigens.

A Hamann1, H W Doerr.   

Abstract

We investigated the IgG subclass reactivity pattern to early antigens (EA) of human cytomegalovirus (HCMV) in 217 EA-antibody-positive sera from immunocompetent, healthy persons, renal transplant recipients and AIDS patients by immunoblotting. All IgG subclasses are involved in the IgG immune response to HCMV EA. IgG 1 was the major subclass reacting with HCMV EA (with a molecular mass ranging between 23- and 79-kDa) and was present in all sera irrespective of origin. Antibody responses of IgG isotypes 2, 3 and 4 were observed with lower frequency and reactivity, whereas IgG 3 was detectable more frequently and reacted slightly stronger than IgG 2 and 4. The IgG 1 reactivity pattern was similar to that seen with total IgG. In contrast to total IgG and IgG 1, the reactivity of the sub-classes 2, 3 and 4 was not equally distributed among the early polypeptides, but was mainly directed to some of them (79-, 70-, 66-, 43- and 38-kDa). On average primary infections seem to induce a stronger IgG 3 response to the 79-, 70- and 38-kDa proteins than reactivated infections and an increased IgG 1 to the 79-, 70-, 59-, 56- and 50-kDa proteins appeared to be associated with severe disease. Noteworthy was the significantly lower prevalence of IgG 1 antibodies to the 70-kDa protein in human immunodeficiency virus (HIV)-infected individuals when compared to renal transplant recipients and immunocompetent, healthy individuals. Since the IgG 1 immune reaction to this protein occurred five to seven times more frequently in healthy persons and renal transplant recipients, the decreased formation of IgG 1 antibodies to the 70-kDa protein might be a characteristic feature of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1664488     DOI: 10.1007/bf00215248

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  18 in total

1.  Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients.

Authors:  T H The; H K Andersen; E S Spencer; G Klein
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

2.  Properties of IgG subclasses to human cytomegalovirus.

Authors:  G Gilljam; B Wahren
Journal:  J Virol Methods       Date:  1989-08       Impact factor: 2.014

3.  Characterization of the major immediate-early polypeptides encoded by murine cytomegalovirus.

Authors:  G M Keil; M R Fibi; U H Koszinowski
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

4.  Modified diffusion blotting for rapid and efficient protein transfer with PhastSystem.

Authors:  W Braun; R Abraham
Journal:  Electrophoresis       Date:  1989-04       Impact factor: 3.535

5.  Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay.

Authors:  J M Middeldorp; J Jongsma; A ter Haar; J Schirm; T H The
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

6.  Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections.

Authors:  G A Linde; L Hammarström; M A Persson; C I Smith; V A Sundqvist; B Wahren
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

7.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

8.  Detection of antibody to cytomegalovirus early antigen in vaccinated, normal volunteers and renal transplant candidates.

Authors:  A D Friedman; T Furukawa; S A Plotkin
Journal:  J Infect Dis       Date:  1982-08       Impact factor: 5.226

9.  IgG-subclass-specific CMV reactivity in bone marrow transplant recipients.

Authors:  B Wahren; A Linde; V A Sundqvist; P Ljungman; B Lönnqvist; O Ringdén
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

10.  Complement-fixing antibodies to human cytomegalovirus induced early nuclear antigens in mononucleosis.

Authors:  L Gergely; J Gzeglédy; L Váczi
Journal:  Med Microbiol Immunol       Date:  1981       Impact factor: 3.402

View more
  3 in total

1.  EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

Authors:  K Bickham; C Münz; M L Tsang; M Larsson; J F Fonteneau; N Bhardwaj; R Steinman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Laboratory diagnosis of congenital human cytomegalovirus infection using polymerase chain reaction and shell vial culture.

Authors:  B Weber; M Opp; H J Born; U Langenbeck; H W Doerr
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

Review 3.  Humoral immune response to human cytomegalovirus infection: diagnostic potential of immunoglobulin class and IgG subclass antibody response to human cytomegalovirus early and late antigens.

Authors:  B Weber; W Braun; J Cinatl; H W Doerr
Journal:  Clin Investig       Date:  1993-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.